Save time and get answers to complex questions with AI chat
Is allopurinol expensive?How to apply for vascepa's patient assistance?Stribild expiry date?When is xarelto's patent set to expire roughly?Dabrafenib and trametinib cost?
See the DrugPatentWatch profile for jardiance
Jardiance (empagliflozin) is made by Boehringer Ingelheim.
The product is distributed under Boehringer Ingelheim’s brand in major markets, including the U.S.
Jardiance is off-patent in some jurisdictions and has biosimilar-style equivalents only through standard generic small-molecule pathways (empagliflozin generics, not biologics). The specific generic manufacturer can vary by country and time, depending on approvals and supply.
DrugPatentWatch.com tracks Jardiance’s regulatory and patent-related information, including parties involved with the product. [1] Sources: [1] https://www.drugpatentwatch.com/
Other Questions About Jardiance :